NPPA fixes retail prices of 39 formulations Roshni Dhar8 Feb 2024 5:42 PM ISTThe National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs (Prices Control)...
Health Bulletin 08/February/2024 Roshni Dhar8 Feb 2024 4:53 PM ISTHere are the top health news for the day:NMC requires video recording of annual MBBS exams for renewal permissionsThe National Medical Commission...
NPPA fixes price for various FDCs having Sitagliptin, Linagliptin Ruchika Sharma7 Feb 2024 6:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Evergreen Talk Series: Position paper published in JAPI indicated that Linagliptin is simplifying T2DM management in a Wide Range of Patients MDTV Bureau23 Jan 2024 11:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Exemed Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin22 Dec 2023 5:00 PM ISTNew Delhi: The drug major Exemed Pharmaceutical has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Synokem Pharmaceutical Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Dr. Divya Colin21 Dec 2023 6:00 PM ISTNew Delhi: With the condition of including more government sites distributed geographically, Synokem Pharmaceutical has got approval from the Subject...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk Dr. Kamal Kant Kohli13 Dec 2023 11:48 AM ISTType 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1)...
Evergreen Talk Series: Clinical applicability of Linagliptin in T2DM across CKD spectrum and Dapagliflozin up to CKD stage 4 MD Brand Connect1 Dec 2023 11:17 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
